Inhaled corticosteroids for the treatment of COVID-19-Reference-Cited by-同舟云学术

Inhaled corticosteroids for the treatment of COVID-19

Published:2022-03-09 Issue:3 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Griesel Mirko¹,Wagner Carina²,Mikolajewska Agata³⁴,Stegemann Miriam³,Fichtner Falk¹,Metzendorf Maria-Inti⁵,Nair Avinash Anil⁶,Daniel Jefferson⁷,Fischer Anna-Lena¹,Skoetz Nicole²

Affiliation:

1. Department of Anesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany

2. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

3. Department of Infectious Diseases and Respiratory Medicine; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

4. Centre for Biological Threats and Special Pathogens (ZBS), Strategy and Incident Response, Clinical Management and Infection Control; Robert Koch Institute; Berlin Germany

5. Cochrane Metabolic and Endocrine Disorders Group; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

6. Department of Respiratory Medicine; Christian Medical College; Vellore India

7. Department of Pulmonary Medicine; Christian Medical College; Vellore India

Publisher

Wiley

Subject

Pharmacology (medical)

Reference88 articles.

1. A randomised controlled trial of inhaled ciclesonide for outpatient treatment of symptomatic COVID-19 infections;Clemency;medRxiv,2021

2. Inhaled budesonide in the treatment of early COVID-19(STOIC): a phase 2, open-label, randomised controlled trial;Ramakrishnan;Lancet Respiratory Medicine,2021

3. Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial;Ramakrishnan;medRxiv,2021

4. STOIC Patient information sheet stoic.ndm.ox.ac.uk/patient-information-sheet

5. Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial;Yu;medRxiv,2021

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes;BMJ Open Respiratory Research;2024-01

2. Clinical course and management of COVID-19 in the era of widespread population immunity;Nature Reviews Microbiology;2023-12-19

3. Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions;Microorganisms;2023-12-11

4. Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka;BMJ Open;2023-12

5. Development of Asthma-Like Symptoms After COVID-19: A Cross-Sectional Study in Dubai, United Arab Emirates;Cureus;2023-11-09